Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Oct 17, 2023 1:30 PM - Oct 17, 2023 5:30 PM

(Central Europe Standard Time)

EMA Clinical Trial Information System (CTIS) Information Day

The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition of their clinical trials to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and EU/EEA member states will share insights and best practices.


Peter Richard Arlett, MD, FFPM, FRCP

Peter Richard Arlett, MD, FFPM, FRCP

Head Data Analytics and Methods Task Force, European Medicines Agency, Netherlands

Peter Arlett is Head of the Data Analytics and Methods Taskforce at the European Medicines Agency. In this role he leads on operations and transformation on clinical evidence at the EMA including clinical trials, real world evidence, safety reporting and data science including AI. He is Chair of the EMA Data Board, Co-Chair of the HMA-EMA Big Data Steering Group, Co-chair of the EMA AI Coordination Group, Co-chair of the Vaccine Monitoring Platform Steering Group and Member of the ACT EU Steering Group In addition to his role at EMA, Peter is Honorary Professor at the London School of Hygiene and Tropical Medicine. He is also a Fellow of the Royal College of Physicians of Edinburgh and of the Faculty of Pharmaceutical Medicines of London

Marianne  Lunzer, DrMed

Marianne Lunzer, DrMed

Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care, AGES, Austria

Marianne is a medical doctor by training and joined AGES in 2008 as a pharmacovigilance assessor. She was an alternate PRAC member between 2015 and 2017. In 2017, she joined the clinical trial unit at AGES as a safety assessor and has since been part of the Clinical Trials Facilitation and Coordination Group (CTFG) group. Since 2022 she is chairing the group now called Clinical trials coordination group (CTCG). Marianne contributed to the CTFG best practice guidelines for safety assessors for clinical trials and is a member of the drafting team for the Commission implementing regulation for the cooperation in safety assessment of clinical trials.

Noemie  Manent, PharmD

Noemie Manent, PharmD

TDA-CTT Operations Workstream Lead, European Medicines Agency, Netherlands

Noémie Manent is the Operations Lead in the Clinical Trial Transformation team at the European Medicines Agency, facilitating change management for member states and sponsors with the implementation of the clinical trial Regulation. She has played an essential role in the set up of structured summary results for clinical trials. Also, she has experience in the coordination of inspections for marketing authorisation application. Noemie has more than 15 years experience working in clinical R&D for small and medium enterprises in industry and academia mainly in France and the United Kingdom.

Laura  Pioppo, MSc

Laura Pioppo, MSc

Scientific Administrator, CTIS expert, European Medicines Agency, Netherlands

Pharmacist with a Master degree in Pharmacovigilance, working experience at EMA in the Compliance and Inspection department, since 2016 working on the development CTIS and leading on CTIS transparency aspects, EMA liaison at the Clinical Trials Coordination Group (CTCG) and from October 2023 Programme Manager for the ACT EU initiative.

Linda  Abdelall

Linda Abdelall

Policy Officer, DG SANTE, European Commission, Belgium

Linda Abdelall works on Clinical Trials at the European Commission, DG SANTE since April 2022. She coordinates the Clinical Trials Coordination and Advisory Group (CTAG) and the European Commission’s Clinical Trial Expert Group (CTEG). She is a pharmacist by training and has a MSc degree in Governance and Leadership in European Public Health from Maastricht University.

Scott  Feiner

Scott Feiner

Senior Manager, Trial Disclosure, AbbVie, United States

Scott has over a decade of experience with clinical trial disclosure, initially working for smaller sponsors as a one-person clinical trial disclosure department, to later operating in larger organizations, serving as an expert in summary results reporting and clinical document redaction/anonymization for public disclosure. As part of implementation planning for the EU Clinical Trials Regulation, Scott is AbbVie’s representative in the EMA CTIS sponsor master trainer programme.

Caroline  Correas, MA

Caroline Correas, MA

Associate Director, Global Regulatory Policy , Switzerland

Caroline is Associate Director in Global Regulatory Policy at Bristol Myers Squibb, based in Switzerland. She holds a Masters Degree in Political Sciences from Sciences Po Paris with a specialization in European Law. She has been working in the pharmaceutical industry for the past ten years. She has been working on preparing her organization and the industry in general for the implementation of the Clinical Trials Regulation since 2017. In particular, she has been leading the industry's efforts relevant to transitioning clinical trials from the Clinical Trials Directive to the Clinical Trials Regulation since 2021, through cross-trade associations (representing big and small companies, commercial & academic sponsors) advocacy activities.

Leonard  van den Berg

Leonard van den Berg

, University Medical Center Utrecht (UMC) , Netherlands

Leonard H. van den Berg is a professor of neurology who holds a chair in neurology focused on Motor Neuron Disorders at the University Medical Center Utrecht in the Netherlands. He is founder and director of the Netherlands ALS Center,and chair of the European Network to Cure ALS (ENCALS), a network of the European ALS Centres, and of TRICALS, a European Trial Consortium. As a practicing neurologist specializing in neuromuscular diseases, a major emphasis of his research has been in ALS and other motor neuron disorders, and he has been a principle investigator on numerous drug trials concerning treatment options for these diseases. He is author of over 650 peer reviewed publications.

Maria Elena  García Méndez

Maria Elena García Méndez

Pharmacist, member of the Technical Secretariat of the Ethics Committee, Universitary Hospital La Paz, Spain

Elena García Méndez is a Pharmacist, with post-graduate courses for a PhD program in Microbiology and a Master's Degree in Clinical Bioethics. She has an extensive experience in clinical research with drugs and advanced therapies in different therapeutic areas and in all phases of clinical development. She worked for 30 years in the Clinical Research/Operations department of a multinational pharmaceutical company holding different positions with increasing responsibility (from CRA to Head of Clinical Operations). She joined the Technical Secretariat of the Ethics Committee for the Research with Medicinal Products of Universitary Hospital La Paz - Hospital Cantoblanco - Hospital Carlos III in March 2021.

Laura  Lavin de Juan

Laura Lavin de Juan

Head of Service in the Clinical Trials Division , Spanish Agency of Medicines and Medical Devices (AEMPS), Spain

Laura is a Clinical assessor in the Clinical Trials Division of the Spanish Agency for Medicines and Medical Devices since January 2021. During the last two years, her focus was primarily on facilitation of the implementation of the Clinical Trials Regulation (CTR) and the Clinical Trials Information System (CTIS) in Spain. Laura was appointed Master Trainer in Spain in November 2021, and manages everything related with the CTR and CTIS since then.

Monique  Al, PhD

Monique Al, PhD

Special advisor CCMO, Central Committee on Research Involving Human Subjects (CCMO), Netherlands

Monique Al is currently special advisor at the Central Committee on Research Involving Human Subjects (CCMO) in The Netherlands. Since May 2023 she is the vice-chair of the Clinical Trial Coordination Group. She is the lead of the CTCG ethics advisory group. Her background is Clinical Nutrition with a PhD in Human Biology. She has worked for several nutritional and pharmaceutical companies in the field of clinical research before she started in 2001 as a scientific staff member at the CCMO.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.